Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: November 3, 2023
Context: The filing discloses the receipt of a notification from Nasdaq regarding the Company's failure to maintain the minimum bid price requirement for its common stock.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a regulatory notification and does not contain financial statements or operational metrics.
Material Changes
The material event reported is the receipt of a Nasdaq Minimum Bid Price Notification. This indicates that the Company's stock price has fallen below the minimum threshold required for continued listing on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release (Exhibit 99.1) detailing the notification but does not include specific management commentary, future guidance, or operational outlook within the body of this Form 6-K.
Risks: The primary risk highlighted is the potential delisting from Nasdaq if the Company fails to regain compliance with the minimum bid price requirement within the timeframe specified by the exchange.
Investor Verification Checklist
- Verify the specific date and terms of the Nasdaq Minimum Bid Price Notification.
- Review the Company's plan to regain compliance with Nasdaq listing standards.
- Check the current trading price of Icecure Medical Ltd. common stock relative to the $1.00 minimum bid price requirement.
- Examine the full text of the press release filed as Exhibit 99.1 for details on potential remediation actions.